NCT06796998
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06796998
Title Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Izidore Lossos, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33136 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field